Vestal Point Capital, LP Macrogenics Inc Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Macrogenics Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 280,000 shares of MGNX stock, worth $411,600. This represents 0.02% of its overall portfolio holdings.
Number of Shares
280,000
Previous 280,000
-0.0%
Holding current value
$411,600
Previous $356 Million
4.72%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding MGNX
# of Institutions
118Shares Held
52.3MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$14.6 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$8.76 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$6.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.78 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $90.3M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...